Healthcare Services

Rising Zika Virus Cases Driving Growth in the Therapeutics Market

April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Zika Virus Therapeutics Market Expected To Scale Between 2026 And 2030?

The zika virus therapeutics market size has experienced significant expansion over recent years. It is projected to escalate from $32.06 billion in 2025 to $34 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.0%. The market’s historical growth can be attributed to several factors: prior outbreaks in endemic regions, a reliance on symptomatic treatment approaches, the broadening of public health monitoring systems, the advancement of basic diagnostic tools, and increased understanding of congenital zika complications.

The zika virus therapeutics market size is anticipated to undergo significant expansion in the coming years. It is predicted to reach $42.49 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.7%. This growth during the forecast period is mainly driven by increased funding for infectious disease research, a rising need for preventive vaccines, the expansion of global disease monitoring networks, a heightened emphasis on protecting maternal health, and strengthened partnerships among public health organizations. Key developments expected during this period include an intensified focus on developing antiviral drugs, growing investment in vaccine research initiatives, the broadening of supportive care therapeutic options, enhanced surveillance of vector-borne diseases, and improved public health readiness.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21323&type=smp

Which Factors Are Influencing The Growth Of The Zika Virus Therapeutics Market?

The anticipated expansion of the Zika virus therapeutics market is fueled by the significant prevalence of infection. This rate represents the likelihood or risk of an infection appearing within a particular group over a set timeframe. Various factors contribute to this infection incidence, including insufficient vector management, environmental circumstances conducive to mosquito proliferation, and restricted availability of preventative health services in impacted areas. The increasing occurrence of infection necessitates potent Zika virus therapeutics, thus stimulating the creation and funding of vaccines and treatments to address this escalating public health danger. An illustrative example comes from December 2024, when the UK Health Security Agency, a UK-based government organization, reported approximately eight confirmed Zika virus cases between January and June 2024. This demonstrated a substantial 700% rise in incidence compared to the equivalent period in 2023. Consequently, the escalating infection rate will inevitably propel the expansion of the Zika virus therapeutics market.

How Is The Zika Virus Therapeutics Market Organized By Segment Classification?

The zika virus therapeutics market covered in this report is segmented –

1) By Product: Acetaminophen, Other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

2) By Vaccine Type: Inactivated Vaccine, Subunit Vaccine, Live-Attenuated Vaccine, Other Vaccine Types

3) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Acetaminophen: Oral Tablets, Oral Suspensions, Intravenous Formulations

2) By Other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Celecoxib

Which Trends Are Influencing Demand In The Zika Virus Therapeutics Market?

Major companies operating in the zika virus therapeutics market are prioritizing the development of innovative technologies, such as second-generation adjuvanted inactivated vaccines, aimed at boosting immune responses, enhancing vaccine efficacy, and providing more durable protection against the virus. A second-generation adjuvanted inactivated vaccine is defined as one that combines an inactivated virus with an immune-enhancing adjuvant to amplify the body’s immune reaction for superior defense against the target disease. As an illustration, in March 2024, Valneva SE, a France-based biotechnology company involved in vaccine manufacturing, announced the initiation of Phase 1 clinical trials for VLA1601. This highly purified inactivated vaccine candidate targets Zika virus (ZIKV) and was developed using the identical manufacturing platform as Valneva’s licensed Japanese encephalitis vaccine, IXIARO. The vaccine is adjuvanted, meaning it contains substances that improve the immune response, which is crucial for its overall effectiveness.

Who Are The Industry Participants Involved In The Zika Virus Therapeutics Market?

Major companies operating in the zika virus therapeutics market are Johnson & Johnson, Merck & Co Inc, Sanofi S A, Takeda Pharmaceutical Company Limited, Moderna Inc, Emergent BioSolutions Inc, Valneva SE, Bharat Biotech International Limited, Inovio Pharmaceuticals Inc, GeoVax Labs Inc, GlaxoSmithKline plc, Novavax Inc, Pfizer Inc, GeneOne Life Science Inc, Zydus Cadila, Indian Immunologicals Limited, Enesi Pharma, Protein Sciences Corporation, Sementis Ltd, Hawaii Biotech Inc, GeneOne Life Science

Get The Full Zika Virus Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/zika-virus-therapeutics-global-market-report

Where Is The Zika Virus Therapeutics Market Primarily Concentrated By Region?

North America was the largest region in the zika virus therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zika virus therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Zika Virus Therapeutics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/zika-virus-therapeutics-global-market-report

Browse Through More Reports Similar to the Global Zika Virus Therapeutics Market 2026, By The Business Research Company

Antiviral Combination Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/antiviral-combination-therapy-global-market-report

Oncolytic Virus Therapy Market Report

https://www.thebusinessresearchcompany.com/report/oncolytic-virus-therapy-global-market-report

Antivirals Market Report

https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795